Citations (96)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yuling Xing, Jinhu Chen, Jing Liu, Guangyao Song & Huijuan Ma. (2022) Relationship Between Serum Uric Acid-to-Creatinine Ratio and the Risk of Metabolic-Associated Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity 15, pages 257-267.
Read now
Read now
Jozaa Z. ALTamimi, Ghedeir M. Alshammari, Nora A. AlFaris, Reham I. Alagal, Dalal H. Aljabryn, Norah A. Albekairi, Mahmoud Ahmad Alkhateeb & Mohammed Abdo Yahya. (2022) Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK. Pharmaceutical Biology 60:1, pages 25-37.
Read now
Read now
Fan Yang, Ping Huang, Liandong Shi, Feng Liu, Aimei Tang & Shaohui Xu. (2020) Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice. Drug Design, Development and Therapy 14, pages 3865-3874.
Read now
Read now
Parvin Farzanegi, Amir Dana, Zeynab Ebrahimpoor, Mahdieh Asadi & Mohammad Ali Azarbayjani. (2019) Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. European Journal of Sport Science 19:7, pages 994-1003.
Read now
Read now
Bregje Van De Wier, Ger H. Koek, Aalt Bast & Guido R. M. M. Haenen. (2017) The potential of flavonoids in the treatment of non-alcoholic fatty liver disease. Critical Reviews in Food Science and Nutrition 57:4, pages 834-855.
Read now
Read now
Articles from other publishers (91)
Brian J. Engel, Vincenzo Paolillo, Md. Nasir Uddin, Kristyn A. Gonzales, Kathryn M. McGinnis, Margie N. Sutton, Madhavi Patnana, Brian J. Grindel, Gregory J. Gores, David Piwnica-Worms, Laura Beretta, Federica Pisaneschi, Seth T. Gammon & Steven W. Millward. (2023) Gender Differences in a Mouse Model of Hepatocellular Carcinoma Revealed Using Multi-Modal Imaging. Cancers 15:15, pages 3787.
Crossref
Crossref
Daiana Barcarolo, Emmanuel Angeli, Lucas Etchevers, Lucas E. Ribas, Valentina Matiller, Florencia Rey, Hugo H. Ortega & Gustavo J. Hein. (2023) Effect of Parenteral Supplementation of Minerals and Vitamins on Oxidative Stress Biomarkers and Hepatic Fatty Acid Metabolism in Dairy Cows During the Transition Period. Biological Trace Element Research.
Crossref
Crossref
Jessica Jessica, I Made Winarsa Ruma & I Gusti Ayu Widianti. (2023) Burdock Root (Arctium lappa) Reduces Steatosis and Serum Malondialdehyde in Wistar Rats Fed with Used Cooking Oil. European Journal of Biomedical Research 2:3, pages 1-5.
Crossref
Crossref
Qing Zheng, Min Zhu, Xin Zeng, Wen Liu, Fudong Fu, Xiaoyu Li, Guangneng Liao, Yanrong Lu & Younan Chen. (2023) Comparison of Animal Models for the Study of Nonalcoholic Fatty Liver Disease. Laboratory Investigation 103:7, pages 100129.
Crossref
Crossref
Kelly N Z Fuller, Julie Allen, Roshan Kumari, Jephte Y Akakpo, Meghan Ruebel, Kartik Shankar & John P Thyfault. (2023) Pre– and Post–Sexual Maturity Liver-specific ERα Knockout Does Not Impact Hepatic Mitochondrial Function. Journal of the Endocrine Society 7:6.
Crossref
Crossref
Doreen Onyinye Anene, Yeasmin Akter, Peter John Groves, Neil Horadagoda, Sonia Yun Liu, Amy Moss, Christine Hutchison & Cormac John O’Shea. (2023) Association of feed efficiency with organ characteristics and fatty liver haemorrhagic syndrome in laying hens. Scientific Reports 13:1.
Crossref
Crossref
Satu Pekkala. (2023) Fecal Metagenomics and Metabolomics Identifying Microbial Signatures in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 24:5, pages 4855.
Crossref
Crossref
Manfredi Rizzo, Alessandro Colletti, Peter E. Penson, Niki Katsiki, Dimitri P. Mikhailidis, Peter P. Toth, Ioanna Gouni-Berthold, John Mancini, David Marais, Patrick Moriarty, Massimiliano Ruscica, Amirhossein Sahebkar, Dragos Vinereanu, Arrigo Francesco Giuseppe Cicero, Maciej Banach, Julio Acosta, Mutaz Al-Khnifsawi, Fahad Alnouri, Fahma Amar, Atanas G. Atanasov, Gani Bajraktari, Maciej Banach, Ioanna Gouni-Berthold, Sonu Bhaskar, Agata Bielecka-Dąbrowa, Bojko Bjelakovic, Eric Bruckert, Ibadete Bytyçi, Alberto Cafferata, Richard Ceska, Arrigo F.G. Cicero, Krzysztof Chlebus, Xavier Collet, Magdalena Daccord, Olivier Descamps, Dragan Djuric, Ronen Durst, Marat V. Ezhov, Zlatko Fras, Dan Gaita, Ioanna Gouni-Berthold, Adrian V. Hernandez, Steven R. Jones, Jacek Jozwiak, Nona Kakauridze, Amani Kallel, Niki Katsiki, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, G.B. John Mancini, A. David Marais, Seth S. Martin, Julio Acosta Martinez, Mohsen Mazidi, Dimitri P. Mikhailidis, Erkin Mirrakhimov, Andre R. Miserez, Olena Mitchenko, Natalya P. Mitkovskaya, Patrick M. Moriarty, Seyed Mohammad Nabavi, Devaki Nair, Demosthenes B. Panagiotakos, György Paragh, Daniel Pella, Peter E. Penson, Zaneta Petrulioniene, Matteo Pirro, Arman Postadzhiyan, Raman Puri, Ashraf Reda, Željko Reiner, Dina Radenkovic, Michał Rakowski, Jemaa Riadh, Dimitri Richter, Manfredi Rizzo, Massimiliano Ruscica, Amirhossein Sahebkar, Maria-Corina Serban, Abdullah M.A Shehab, Aleksandr B. Shek, Cesare R. Sirtori, Claudia Stefanutti, Tomasz Tomasik, Peter P. Toth, Margus Viigimaa, Pedro Valdivielso, Dragos Vinereanu, Branislav Vohnout, Stephan von Haehling, Michal Vrablik, Nathan D. Wong, Hung-I Yeh, Jiang Zhisheng & Andreas Zirlik. (2023) Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP). Pharmacological Research 189, pages 106679.
Crossref
Crossref
Francesco Bellanti, Aurelio Lo Buglio & Gianluigi Vendemiale. (2023) Hepatic Mitochondria-Gut Microbiota Interactions in Metabolism-Associated Fatty Liver Disease. Metabolites 13:3, pages 322.
Crossref
Crossref
Pedro H. Reis-Barbosa, Thatiany Souza Marinho, Cristiane Matsuura, Marcia Barbosa Aguila, Jorge J. de Carvalho & Carlos Alberto Mandarim-de-Lacerda. (2022) The obesity and nonalcoholic fatty liver disease mouse model revisited: Liver oxidative stress, hepatocyte apoptosis, and proliferation. Acta Histochemica 124:7, pages 151937.
Crossref
Crossref
Hanzhang Wu, Xiaolu He, Qian Li, Yunliang Zheng, Sabina Rayamajhi, Amrish Thapa, Ge Meng, Qing Zhang, Li Liu, Hongmei Wu, Yeqing Gu, Shunming Zhang, Tingjing Zhang, Xuena Wang, Juanjuan Zhang, Zhixia Cao, Jun Dong, Xiaoxi Zheng, Xu Zhang, Xinrong Dong, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Hong Chang & Kaijun Niu. (2022) Relationship between the consumption of wholegrain and nonalcoholic fatty liver disease: The TCLSIH cohort study. Clinical Nutrition 41:7, pages 1483-1490.
Crossref
Crossref
Raghu Ramanathan, Ahmad Hassan Ali & Jamal A. Ibdah. (2022) Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 23:13, pages 7280.
Crossref
Crossref
Margalida Monserrat-Mesquida, Magdalena Quetglas-Llabrés, Cristina Bouzas, Sofía Montemayor, Catalina M. Mascaró, Miguel Casares, Isabel Llompart, José M. Gámez, Silvia Tejada, J. Alfredo Martínez, Josep A. Tur & Antoni Sureda. (2022) A Greater Improvement of Intrahepatic Fat Contents after 6 Months of Lifestyle Intervention Is Related to a Better Oxidative Stress and Inflammatory Status in Non-Alcoholic Fatty Liver Disease. Antioxidants 11:7, pages 1266.
Crossref
Crossref
Athanasia Mitsala, Christos Tsalikidis, Konstantinos Romanidis & Michail Pitiakoudis. (2022) Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?. Current Oncology 29:7, pages 4478-4510.
Crossref
Crossref
Shu ZengFan WuMengyue ChenYun LiMengyue YouYang ZhangPing YangLi WeiXiong Z. RuanLei ZhaoYaxi Chen. (2022) Inhibition of Fatty Acid Translocase (FAT/CD36) Palmitoylation Enhances Hepatic Fatty Acid β-Oxidation by Increasing Its Localization to Mitochondria and Interaction with Long-Chain Acyl-CoA Synthetase 1. Antioxidants & Redox Signaling 36:16-18, pages 1081-1100.
Crossref
Crossref
Kylynda C. Bauer, Paula T. Littlejohn, Victoria Ayala, Anna Creus-Cuadros & B. Brett Finlay. (2022) Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective. Gastroenterology 162:7, pages 1858-1875.e2.
Crossref
Crossref
Retno Susilowati, Abdul Malik Setiawan, Afida Fatimatuz Zahroh, Zadani Nabila Ashari, Alifatul Iffiyana, Ricky Hertanto, Muhammad Basyarudin, Isnaeni Hartiningsih & Mahrus Ismail. (2022) Hepatoprotection of Cinnamomum burmannii ethanolic extract against high-fat and cholesterol diet in Sprague–Dawley rats (Rattus norvegicus). Veterinary World, pages 930-936.
Crossref
Crossref
Da Hyun Lee, Jeong Su Park, Yu Seol Lee & Soo Han Bae. (2022) PERK prevents hepatic lipotoxicity by activating the p62-ULK1 axis-mediated noncanonical KEAP1-Nrf2 pathway. Redox Biology 50, pages 102235.
Crossref
Crossref
Ayokanmi Ore, Oluseyi Adeboye Akinloye, Abideen Idowu Adeogun, Regina Ngozi Ugbaja, Eric Morifi, Maya Makatini, Refilwe Moepya & Thapelo Mbhele. (2021)
Buchholzia coriacea
seed (wonderful kolanut) alleviates insulin resistance, steatosis, inflammation and oxidative stress in high fat diet model of fatty liver disease
. Journal of Food Biochemistry 46:3.
Crossref
Crossref
Özlem ALPTEKİN, Sevde Seyhan TUKEL, Belma TURAN & Yurdun KUYUCU. (2022) Alterations in Antioxidant Defence Systems and Metal Profiles in Liver of Rats with Metabolic Syndrome Induced with High-Sucrose Diet. Journal of the Turkish Chemical Society Section A: Chemistry 9:1, pages 13-20.
Crossref
Crossref
Jing Zhu, Jiexia Ding, Siying Li & Jie Jin. (2022) Ganoderic acid A ameliorates non‑alcoholic streatohepatitis (NASH) induced by high‑fat high‑cholesterol diet in mice. Experimental and Therapeutic Medicine 23:4.
Crossref
Crossref
Ju-Yeon Kim, In Sook Yang, Hyeon-Ji Kim, Jae-Yeun Yoon, Yong-Hyun Han, Je Kyung Seong & Mi-Ock Lee. (2022) RORα contributes to the maintenance of genome ploidy in the liver of mice with diet-induced nonalcoholic steatohepatitis. American Journal of Physiology-Endocrinology and Metabolism 322:2, pages E118-E131.
Crossref
Crossref
Zeinab El Rashed, Elena Grasselli, Hala Khalifeh, Laura Canesi & Ilaria Demori. (2020) Brown-Algae Polysaccharides as Active Constituents against Nonalcoholic Fatty Liver Disease. Planta Medica 88:01, pages 9-19.
Crossref
Crossref
Hitoshi Maeda, Yu Ishima, Junji Saruwatari, Yuki Mizuta, Yuki Minayoshi, Shota Ichimizu, Hiroki Yanagisawa, Taisei Nagasaki, Kengo Yasuda, Shun Oshiro, Manabu Taura, Matthew J. McConnell, Kentaro Oniki, Kayoko Sonoda, Tomohiko Wakayama, Manabu Kinoshita, Tsuyoshi Shuto, Hirofumi Kai, Motohiko Tanaka, Yutaka Sasaki, Yasuko Iwakiri, Masaki Otagiri, Hiroshi Watanabe & Toru Maruyama. (2022) Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH. Journal of Controlled Release 341, pages 457-474.
Crossref
Crossref
Hüseyin Vural, Ferah Armutcu, Omer Akyol & Ralf Weiskirchen. (2021) The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases. Clinica Chimica Acta 523, pages 374-379.
Crossref
Crossref
Danijela Ristic-Medic, Snjezana Petrovic, Aleksandra Arsic & Vesna Vucic. (2021) Liver disease and COVID-19: The link with oxidative stress, antioxidants and nutrition. World Journal of Gastroenterology 27:34, pages 5682-5699.
Crossref
Crossref
Pintu Miah, Surovi Binte Sharmin Mohona, Md. Mizanur Rahman, Nusrat Subhan, Ferdous Khan, Hemayet Hossain, Shazid Md. Sharker & Md. Ashraful Alam. (2021) Supplementation of cumin seed powder prevents oxidative stress, hyperlipidemia and non-alcoholic fatty liver in high fat diet fed rats. Biomedicine & Pharmacotherapy 141, pages 111908.
Crossref
Crossref
Guoyi Tang, Yu Xu, Cheng Zhang, Ning Wang, Huabin Li & Yibin Feng. (2021) Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism. Antioxidants 10:7, pages 1076.
Crossref
Crossref
Hiteshi Dhami-Shah, Rama Vaidya, Manasi Talwadekar, Eisha Shaw, Shobha Udipi, Ullas Kolthur-Seetharam & Ashok D.B. Vaidya. (2021) Intervention by picroside II on FFAs induced lipid accumulation and lipotoxicity in HepG2 cells. Journal of Ayurveda and Integrative Medicine 12:3, pages 465-473.
Crossref
Crossref
Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae & Kyoung-Jin Oh. (2021) Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. International Journal of Molecular Sciences 22:9, pages 4495.
Crossref
Crossref
Susara Madduma Hewage, Suvira Prashar, Karmin O & Yaw L. Siow. (2021) Lingonberry Improves Non-Alcoholic Fatty Liver Disease by Reducing Hepatic Lipid Accumulation, Oxidative Stress and Inflammatory Response. Antioxidants 10:4, pages 565.
Crossref
Crossref
Wanwisa Deenin, Wachirawadee Malakul, Tantip Boonsong, Ittipon Phoungpetchara & Sakara Tunsophon. (2021) Papaya improves non-alcoholic fatty liver disease in obese rats by attenuating oxidative stress, inflammation and lipogenic gene expression. World Journal of Hepatology 13:3, pages 315-327.
Crossref
Crossref
Clemence M. Canivet, Norma David, Helene Pailhoriès, Martial Briand, Cynthia D. Guy, Olivier Bouchez, Gilles Hunault, Lionel Fizanne, Adrien Lannes, Frederic Oberti, Isabelle Fouchard, Paul Calès, Anna Mae Diehl, Matthieu Barret & Jerome Boursier. (2021) Cross‐linkage between bacterial taxonomy and gene functions: a study of metagenome‐assembled genomes of gut microbiota in adult non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 53:6, pages 722-732.
Crossref
Crossref
Krzysztof Drygalski, Katarzyna Siewko, Andrzej Chomentowski, Cezary Odrzygóźdź, Anna Zalewska, Adam Krętowski & Mateusz Maciejczyk. (2021) Phloroglucinol Strengthens the Antioxidant Barrier and Reduces Oxidative/Nitrosative Stress in Nonalcoholic Fatty Liver Disease (NAFLD). Oxidative Medicine and Cellular Longevity 2021, pages 1-18.
Crossref
Crossref
Serkan Tursun, Hacer Fulya Gülerman, Serkal Gazyağcı, Yaşar Şahin, Özcan Erel & Salim Neşelioğlu. (2021) Investigation of Thiol/Disulfide Balance in Obese Rats with Non-Alcoholic Fatty Liver Disease. Pediatric Gastroenterology, Hepatology & Nutrition 24:5, pages 443.
Crossref
Crossref
AhmedA Hassan, MohieeE.-D.A El-Aziz Awad, HananH Soliman, RedaA.F Usef & DinaS Ata. (2021) Serum ferritin level as a noninvasive marker for detection and staging of hepatocellular injury, liver fibrosis, and steatosis in children and adolescents with nonalcoholic fatty liver disease. Alexandria Journal of Pediatrics 34:3, pages 253.
Crossref
Crossref
Noriko Suzuki-Kemuriyama, Akari Abe, Sae Nakane, Kinuko Uno, Shuji Ogawa, Atsushi Watanabe, Ryuhei Sano, Megumi Yuki, Katsuhiro Miyajima & Dai Nakae. (2021) Extract of <i>Siraitia grosvenorii</i> (Luo Han Guo) protects against hepatic fibrosis in mice on a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet without trans fatty acids. Fundamental Toxicological Sciences 8:5, pages 135-145.
Crossref
Crossref
Collins NIMAKO, Yoshinori IKENAKA, Yuko OKAMATSU-OGURA, Jussiaea V. BARIUAN, Atsushi KOBAYASHI, Ryo YAMAZAKI, Kumiko TAIRA, Nobuhiko HOSHI, Tetsushi HIRANO, Shouta M. M. NAKAYAMA & Mayumi ISHIZUKA. (2021) Chronic low-dose exposure to imidacloprid potentiates high fat diet-mediated liver steatosis in C57BL/6J male mice. Journal of Veterinary Medical Science 83:3, pages 487-500.
Crossref
Crossref
Gehad A. Abdel Jaleel, Sally A. Al-Awdan, Rania F. Ahmed, Omar A.H. Ahmed-Farid & Dalia O. Saleh. (2020) Melatonin regulates neurodegenerative complications associated with NAFLD via enhanced neurotransmission and cellular integrity: a correlational study. Metabolic Brain Disease 35:8, pages 1251-1261.
Crossref
Crossref
Sok Kuan Wong, Kok-Yong Chin, Fairus Ahmad & Soelaiman Ima-Nirwana. (2020) Regulation of inflammatory response and oxidative stress by tocotrienol in a rat model of non-alcoholic fatty liver disease. Journal of Functional Foods 74, pages 104209.
Crossref
Crossref
Milena Vesković, Milica Labudović-Borović, Dušan Mladenović, Jelena Jadžić, Bojan Jorgačević, Dušan Vukićević, Danijela Vučević & Tatjana Radosavljević. (2020) Effect of Betaine Supplementation on Liver Tissue and Ultrastructural Changes in Methionine–Choline-Deficient Diet-Induced NAFLD. Microscopy and Microanalysis 26:5, pages 997-1006.
Crossref
Crossref
Cai-Yu Lian, Zhen-Zhen Zhai, Zi-Fa Li & Lin Wang. (2020) High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chemico-Biological Interactions 330, pages 109199.
Crossref
Crossref
Patricia Rada, Águeda González-Rodríguez, Carmelo García-Monzón & Ángela M. Valverde. (2020) Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?. Cell Death & Disease 11:9.
Crossref
Crossref
Eleonora Cremonini, Dario E. Iglesias, Jiye Kang, Giovanni E. Lombardo, Zahra Mostofinejad, Ziwei Wang, Wei Zhu & Patricia I. Oteiza. (2020) (−)-Epicatechin and the comorbidities of obesity. Archives of Biochemistry and Biophysics 690, pages 108505.
Crossref
Crossref
Ammar Salehi-Sahlabadi, Amin Mokari, Maryam ElhamkiaFariba FarahmandMasoumeh Jabbari & Azita Hekmatdoost. (2020) Dietary Total Antioxidant Capacity and Risk of Non-Alcoholic Fatty Liver Disease: A Case‐Control Study. Journal of Research in Health Sciences 20:3, pages e00486-e00486.
Crossref
Crossref
Shira Zelber-Sagi, Dana Ivancovsky-Wajcman, Naomi Fliss-Isakov, Michal Hahn, Muriel Webb, Oren Shibolet, Revital Kariv & Oren Tirosh. (2020) Serum Malondialdehyde is Associated with Non-Alcoholic Fatty Liver and Related Liver Damage Differentially in Men and Women. Antioxidants 9:7, pages 578.
Crossref
Crossref
Naruemon Wikan, Jiraporn Tocharus, Sivanan Sivasinprasasn, Aphisek Kongkaew, Waraluck Chaichompoo, Apichart Suksamrarn & Chainarong Tocharus. (2020) Capsaicinoid nonivamide improves nonalcoholic fatty liver disease in rats fed a high-fat diet. Journal of Pharmacological Sciences 143:3, pages 188-198.
Crossref
Crossref
Yu Yang, Yu Zhao, Wenzhen Li, Yuyao Wu, Xin Wang, Yijie Wang, Tingmei Liu, Tinghong Ye, Yongmei Xie, Zhiqiang Cheng, Jun He, Peng Bai, Yiwen Zhang & Liang Ouyang. (2020) Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment. European Journal of Medicinal Chemistry 197, pages 112311.
Crossref
Crossref
Marzieh Mahmoodi, Razieh Hosseini, Asma Kazemi, Richard Ofori‐Asenso, Mohsen Mazidi & Seyed Mohammad Mazloomi. (2020) Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta‐analysis of randomized clinical trials. Phytotherapy Research 34:7, pages 1587-1598.
Crossref
Crossref
Somayyeh Asghari, Soudabeh Hamedi‐Shahraki & Farshad Amirkhizi. (2020) Systemic redox imbalance in patients with nonalcoholic fatty liver disease. European Journal of Clinical Investigation 50:4.
Crossref
Crossref
Samuel J. Daniels, Diana J. Leeming, Sönke Detlefsen, Maria F. Bruun, Sara T. Hjuler, Kim Henriksen, Peter Hein, Aleksander Krag, Morten A. Karsdal, Mette Juul Nielsen, Sarah Brockbank & Simon Cruwys. (2020) Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 318:3, pages G410-G418.
Crossref
Crossref
S. Çeribaşı, G. Türk, M. Özçelik, G. Doğan, A.O. Çeribaşı, S. İflazoğlu Mutlu, Z. Erişir, M. Güvenç, G. Güngören, T.C. Acısu, S.A. Akarsu, Ş. Özer Kaya, M. Sönmez, A. Yüce, M. Çiftçi, Z. Çambay, E. Bağcı, M.A. Azman & Ü.G. Şimşek. (2020) Negative effect of feeding with high energy diets on testes and metabolic blood parameters of male Japanese quails, and positive role of milk thistle seed. Theriogenology 144, pages 74-81.
Crossref
Crossref
Miey Park, Jeong-Hyun Yoo, You-Suk Lee, Eun-Jung Park & Hae-Jeung Lee. (2020) Ameliorative effects of black ginseng on nonalcoholic fatty liver disease in free fatty acid–induced HepG2 cells and high-fat/high-fructose diet-fed mice. Journal of Ginseng Research 44:2, pages 350-361.
Crossref
Crossref
Na-Ling Kang, Jie-Min Zhang, Yu-Rui Liu, Su Lin, Jing Dong, Jia-Ji Jiang, Yue-Yong Zhu & Da-Wu Zeng. (2020) Novel predictive models using serum ceruloplasmin levels for hepatic steatosis in patients with chronic hepatitis B infection. Clinics and Research in Hepatology and Gastroenterology 44:1, pages 57-65.
Crossref
Crossref
Kai Wang, Chuanjiang Li, Xinxin Lin, Hang Sun, Ruijuan Xu, Qingping Li, Yiran Wei, Yiyi Li, Jianping Qian, Cuiting Liu, Qifan Zhang, Sheng Yu, Zhonglin Cui, Xixin Huang, Bili Zhu, Jie Zhou & Cungui Mao. (2020) Targeting alkaline ceramidase 3 alleviates the severity of nonalcoholic steatohepatitis by reducing oxidative stress. Cell Death & Disease 11:1.
Crossref
Crossref
Mi Hye Kim, Jung Bae Seong, Jae-Won Huh, Yong Chul Bae, Hyun-Shik Lee & Dong-Seok Lee. (2020) Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling. Redox Biology 28, pages 101315.
Crossref
Crossref
Xiaoli Sun, Jason S. Seidman, Peng Zhao, Ty D. Troutman, Nathanael J. Spann, Xuchu Que, Fangli Zhou, Zhongji Liao, Martina Pasillas, Xiaohong Yang, Jason A. Magida, Tatiana Kisseleva, David A. Brenner, Michael Downes, Ronald M. Evans, Alan R. Saltiel, Sotirios Tsimikas, Christopher K. Glass & Joseph L. Witztum. (2020) Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis. Cell Metabolism 31:1, pages 189-206.e8.
Crossref
Crossref
Marie Usal, Christophe Regnault, Sylvie Veyrenc, Karine Couturier, Cécile Batandier, Anne-Laure Bulteau, David Lejon, Bruno Combourieu, Thomas Lafond, Muriel Raveton & Stéphane Reynaud. (2019) Concomitant exposure to benzo[a]pyrene and triclosan at environmentally relevant concentrations induces metabolic syndrome with multigenerational consequences in Silurana (Xenopus) tropicalis. Science of The Total Environment 689, pages 149-159.
Crossref
Crossref
Michele d’Angelo, Vanessa Castelli, Maria Grazia Tupone, Mariano Catanesi, Andrea Antonosante, Reyes Dominguez-Benot, Rodolfo Ippoliti, Anna Maria Cimini & Elisabetta Benedetti. (2019) Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs. International Journal of Molecular Sciences 20:21, pages 5422.
Crossref
Crossref
Mohamed Diwan M. AbdulHameed, Venkat R. Pannala & Anders Wallqvist. (2019) Mining Public Toxicogenomic Data Reveals Insights and Challenges in Delineating Liver Steatosis Adverse Outcome Pathways. Frontiers in Genetics 10.
Crossref
Crossref
Kate Šešelja, Iva Bazina, Jessica Welss, Martin Schicht, Friedrich Paulsen, Nikola Bijelić, Edi Rođak, Anita Horvatić, Andrea Gelemanović, Martina Mihalj & Mirela Baus Lončar. (2019) Effect of Tff3 Deficiency and ER Stress in the Liver. International Journal of Molecular Sciences 20:18, pages 4389.
Crossref
Crossref
Adriana Fontes, Mireia Alemany-Pagès, Paulo J. Oliveira, João Ramalho-Santos, Hans Zischka & Anabela Marisa Azul. (2019) Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease. International Journal of Molecular Sciences 20:16, pages 3987.
Crossref
Crossref
Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl & Vahid Maleki. (2019) The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic review. Obesity Reviews 20:7, pages 1057-1069.
Crossref
Crossref
Yee Hui Yeo & Yen-Chun Lai. (2019) Redox regulation of metabolic syndrome: recent developments in skeletal muscle insulin resistance and non-alcoholic fatty liver disease (NAFLD). Current Opinion in Physiology 9, pages 79-86.
Crossref
Crossref
Anthony Pinçon, Olivia De Montgolfier, Nilay Akkoyunlu, Caroline Daneault, Philippe Pouliot, Louis Villeneuve, Frédéric Lesage, Bernard I. Levy, Nathalie Thorin-Trescases, Éric Thorin & Matthieu Ruiz. (2019) Non-Alcoholic Fatty Liver Disease, and the Underlying Altered Fatty Acid Metabolism, Reveals Brain Hypoperfusion and Contributes to the Cognitive Decline in APP/PS1 Mice. Metabolites 9:5, pages 104.
Crossref
Crossref
Thomas Senoner, Sophie Schindler, Stefan Stättner, Dietmar Öfner, Jakob Troppmair & Florian Primavesi. (2019) Associations of Oxidative Stress and Postoperative Outcome in Liver Surgery with an Outlook to Future Potential Therapeutic Options. Oxidative Medicine and Cellular Longevity 2019, pages 1-18.
Crossref
Crossref
Dong-Woo Lim, Hyuck Kim, Seung-Jun Lee, Ga-Ram Yu, Jai-Eun Kim & Won-Hwan Park. (2019) Jwa Kum Whan Attenuates Nonalcoholic Fatty Liver Disease by Modulating Glucose Metabolism and the Insulin Signaling Pathway. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-10.
Crossref
Crossref
Ayokanmi Ore & Oluseyi Akinloye. (2019) Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease. Medicina 55:2, pages 26.
Crossref
Crossref
Christine Feillet‐Coudray, Gilles Fouret, Claire Vigor, Béatrice Bonafos, Bernard Jover, Agnieszka Blachnio‐Zabielska, Jennifer Rieusset, François Casas, Sylvie Gaillet, Jean Francois Landrier, Thierry Durand & Charles Coudray. (2019) Long‐Term Measures of Dyslipidemia, Inflammation, and Oxidative Stress in Rats Fed a High‐Fat/High‐Fructose Diet. Lipids 54:1, pages 81-97.
Crossref
Crossref
Su-Kyung Shin, Hyun-Woo Cho, Seung-Eun Song & Dae-Kyu Song. (2018) Catalase and nonalcoholic fatty liver disease. Pflügers Archiv - European Journal of Physiology 470:12, pages 1721-1737.
Crossref
Crossref
Kazuchika Nishitsuji, Syunsuke Watanabe, Jinzhong Xiao, Ryosuke Nagatomo, Hirohisa Ogawa, Takaaki Tsunematsu, Hitomi Umemoto, Yuki Morimoto, Hiroyasu Akatsu, Koichi Inoue & Koichi Tsuneyama. (2018) Effect of coffee or coffee components on gut microbiome and short-chain fatty acids in a mouse model of metabolic syndrome. Scientific Reports 8:1.
Crossref
Crossref
Nadia Panera, Barbara Barbaro, Claudia Della Corte, Antonella Mosca, Valerio Nobili & Anna Alisi. (2018) A review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver disease. Nutrition Research 58, pages 1-16.
Crossref
Crossref
Toshio Itani & Tomoaki Ishihara. (2018) Efficacy of canagliflozin against nonalcoholic fatty liver disease: a prospective cohort study. Obesity Science & Practice 4:5, pages 477-482.
Crossref
Crossref
Lucas Rodolfo de Oliveira RosaAnderson Kiyoshi KagaPedro Octavio BarbaneraPriscila Manfio QueirozNágilla Orleanne Lima do CarmoAna Angélica Henrique Fernandes. (2018)
Beneficial effects of
N
-acetylcysteine on hepatic oxidative stress in streptozotocin-induced diabetic rats
. Canadian Journal of Physiology and Pharmacology 96:4, pages 412-418.
Crossref
Crossref
Sathish Natarajan & Jamal Ibdah. (2018) Role of 3-Hydroxy Fatty Acid-Induced Hepatic Lipotoxicity in Acute Fatty Liver of Pregnancy. International Journal of Molecular Sciences 19:1, pages 322.
Crossref
Crossref
Mariana Verdelho Machado & Anna Mae Diehl. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
369
390.e14
.
Kuan-Hung Lu, Ching-Yi Weng, Wei-Cheng Chen & Lee-Yan Sheen. (2017) Ginseng essence, a medicinal and edible herbal formulation, ameliorates carbon tetrachloride-induced oxidative stress and liver injury in rats. Journal of Ginseng Research 41:3, pages 316-325.
Crossref
Crossref
Raffaelle K Barros, Helma Pinchemel Cotrim, Carla H Daltro & Yanaihara A Oliveira. (2017) Hyperferritinemia in patients with nonalcoholic fatty liver disease. Revista da Associação Médica Brasileira 63:3, pages 284-289.
Crossref
Crossref
Yongjing Zhou, Feifei Wei & Yu Fan. (2016) High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis. Clinical Biochemistry 49:7-8, pages 636-642.
Crossref
Crossref
Caroline Peres Klein, Marcos Rodrigues Cintra, Nancy Binda, Danuza Montijo Diniz, Marcus Vinicius Gomez, Andre Arigony Souto & Alessandra Hubner de Souza. (2016) Coadministration of Resveratrol and Rice Oil Mitigates Nociception and Oxidative State in a Mouse Fibromyalgia-Like Model. Pain Research and Treatment 2016, pages 1-11.
Crossref
Crossref
Sandra Milic, Ivana Mikolasevic, Lidija Orlic, Edita Devcic, Nada Starcevic-Cizmarevic, Davor Stimac, Miljenko Kapovic & Smiljana Ristic. (2016) The Role of Iron and Iron Overload in Chronic Liver Disease. Medical Science Monitor 22, pages 2144-2151.
Crossref
Crossref
Mariana Verdelho Machado, Leandi Kruger, Mark L. Jewell, Gregory Alexander Michelotti, Thiago de Almeida Pereira, Guanhua Xie, Cynthia A. Moylan & Anna Mae Diehl. (2015) Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model. Digestive Diseases and Sciences 61:1, pages 137-148.
Crossref
Crossref
Thing-Fong Tzeng, Yu-Cheng Tzeng, Yu-Jou Cheng, Shorong-Shii Liou & I-Min Liu. (2015) The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model. Nutrients 7:10, pages 8670-8684.
Crossref
Crossref
Margarita Pizarro, Nancy Solís, Pablo Quintero, Francisco Barrera, Daniel Cabrera, Pamela Rojas-de Santiago, Juan P. Arab, Oslando Padilla, Juan C. Roa, Han Moshage, Alexander Wree, Eugenia Inzaugarat, Ariel E. Feldstein, Carlos E. Fardella, Rene Baudrand, Arnoldo Riquelme & Marco Arrese. (2015) Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis. Liver International 35:9, pages 2129-2138.
Crossref
Crossref
Mariana Verdelho Machado, Gregory Alexander Michelotti, Guanhua Xie, Thiago Pereira de Almeida, Jerome Boursier, Brittany Bohnic, Cynthia D. Guy & Anna Mae Diehl. (2015) Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease. PLOS ONE 10:5, pages e0127991.
Crossref
Crossref
Reilly T. Enos, Kandy T. Velázquez, Jamie L. McClellan, Taryn L. Cranford, Michael D. Walla & E. Angela Murphy. (2015) Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model. Nutrition Research 35:5, pages 449-459.
Crossref
Crossref
Jia Liu, Guang Wang, Yumei Jia & Yuan Xu. (2015) GLP-1 receptor agonists: effects on the progression of non-alcoholic fatty liver disease. Diabetes/Metabolism Research and Reviews 31:4, pages 329-335.
Crossref
Crossref
Maísa Silva, Joyce Ferreira da Costa Guerra, Ana Flávia Santos Sampaio, Wanderson Geraldo de Lima, Marcelo Eustáquio Silva & Maria Lucia Pedrosa. (2015) Iron Dextran Increases Hepatic Oxidative Stress and Alters Expression of Genes Related to Lipid Metabolism Contributing to Hyperlipidaemia in Murine Model. BioMed Research International 2015, pages 1-9.
Crossref
Crossref
Waseem Hassan, Lin Ding, Rong-Yin Gao, Jun Liu & Jing Shang. (2014) Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders. Cytokine 66:2, pages 133-142.
Crossref
Crossref
Thing-Fong Tzeng, Shorong-Shii Liou & I.-Min Liu. (2014) 6-Gingerol mitigates nutritional steatohepatitis through regulating key genes related to oxidative stress, inflammation and fibrogenesis. RSC Adv. 4:106, pages 61427-61436.
Crossref
Crossref
A. Yesil & Y. Yilmaz. (2013) Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 38:9, pages 1038-1044.
Crossref
Crossref